Please note: AABB reserves the right to make updates to this program.
Wednesday, April 24, 2024
2:00 – 3:00 PM Eastern Time
Program Number: 24EL-428
Director/Moderator: Andrew Jones, MD, CABP, Medical Director, Progenitor Cell Processing Lab, Staff, Division of Transfusion Medicine, Cleveland Clinic, Cleveland, OH
Speaker: Reggie R. Thomasson, MD, Medical Director, Blood Bank and Transfusion Medicine Service, Associate Director of the Pathology Residency Program, Boston Medical Center; Assistant Professor of Pathology and Laboratory Medicine, Boston University’s Chobanian and Avedisian School of Medicine, Boston, MA
Pre-hospital transfusions occur when emergency personnel administer blood products to hemorrhaging patients in the field and/or in transit. There is growing evidence demonstrating a survival benefit with early transfusion, which is important since hemorrhage continues to be a major preventable cause of death in trauma patients. As the number of pre-hospital transfusion programs are increasing, Dr. Thomasson will review the potential obstacles to establishing a pre-transfusion program, discuss the current evidence regarding which blood products are optimal in the pre-transfusion setting, and discuss the role and responsibilities of the hospital blood bank in supporting these endeavors.
After participating in this educational activity, participants should be able to:
Registration includes access to both the live and on-demand version of this eCast.
If you are a facility interested in participating in this eCast, simply complete the Group Viewing registration form and AABB will provide detailed instructions to share with your team approximately one week prior to the live program (each team member to register for the program utilizing a promocode). For single viewers, simply click on the Register button below to register.
Please note: registration for the live eCast will close 1 hour prior to the eCast start time. If you register after this time you will receive access to the on-demand eCast when it is available.
This activity is eligible for one (1) continuing education credit/contact hour for Physicians, Nurses (including California-based nursing professionals through CBRN), California Lab Personnel, Florida Lab Personnel and General Participation credit. AABB reserves the right to reduce or increase the number of credits granted based on the final activity duration. For more information on each credit type please visit our Continuing Education Credits webpage.
There is no financial support for this activity.
In support of improving patient care, this activity has been planned and implemented by the Association for the Advancement of Blood & Biotherapies (AABB) and CME Outfitters, LLC. CME Outfitters LLC. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME): CME Outfitters, LLC, designates this live activity for a maximum of one (1) AMA PRA Category 1 CreditTM. CME Outfitters, LLC, designates this enduring activity for a maximum of one (1) AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Live Activity - Upon completion of the live activity, you will receive instructions to complete your evaluation, which is necessary to claim credit and receive your certificate of attendance/completion (credit must be claimed by the date provided in the instructions). The evaluation can be found by logging into the AABB Education Platform.
Enduring Activity - Once the enduring (on-demand) program is available, you will receive instructions to access the AABB Education Platform. Upon completion of viewing the enduring activity, you will need to complete the evaluation, which is necessary to claim credit and receive your certificate of completion (credit must be claimed by the date provided in the AABB Education Platform).
Program & Credit Expiration Dates:
Disclosures for the planners of this event can be found here. Disclosures for the program faculty, peer reviewers, and CME Outfitters, LLC. personnel are provided at the beginning of the program.
Andrew Jones, MD, CABP, is the Medical Director of the Progenitor Cell Processing Lab and staff in the division of Transfusion Medicine at the Cleveland Clinic in Cleveland, Ohio. He completed an anatomic and clinical pathology residency at the University of California, Davis, and a fellowship in Blood Banking and Transfusion Medicine at the University of California, San Francisco. He has also obtained the AABB’s Certified Advanced Biotherapies Professional (CABP) certification/credential and serves as a member of the Podcast Team for the monthly podcast for the journal TRANSFUSION. His research interests include quality in the production of laboratory knowledge. received his medical degree from University of Missouri, Columbia, then completed a pathology residency at Dartmouth-Hitchcock Medical Center and a 2-year transfusion medicine fellowship at Mayo Clinic. He is the program director of the Mayo Clinic Blood Banking / Transfusion Medicine fellowship as well as associate medical director of the histocompatibility laboratory. Justin’s primary passion is being an educator. In 2016, he completed the Harvard Macy Institute program for educators in health professions. In 2019, he completed the University of Toronto program for educating health professionals in interprofessional care.
Reggie Thomasson, MD is an Assistant Professor of Pathology and Laboratory Medicine at Boston University’s Chobanian and Avedisian School of Medicine and currently serves as the Medical Director of the Blood Bank and Transfusion Medicine Service at Boston Medical Center as well as the Associate Director of the Pathology Residency Program. He joined the faculty after completing his fellowship in Blood Bank & Transfusion Medicine at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. His professional and clinical interests include massive transfusion, blood product inventory management, sickle cell disease and diversity in medicine. He has been a member of AABB for over five years and currently serves on the DHQ-HPC Task Force and the Awards Committee.